Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1991 Jun;84(3):445–448.

Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space.

R Klein 1, P A Berg 1
PMCID: PMC1535421  PMID: 2044223

Abstract

Testing three anti-M2/anti-M4-positive and three anti-M2 positive/anti-M4-negative primary biliary cirrhosis (PBC) marker sera against different mitochondrial enzymes by ELISA it could be shown that only the anti-M4-positive sera reacted with pyruvate dehydrogenase (M2) and sulphite oxidase (SO), an enzyme of the mitochondrial inter-membrane space in parallel. Absorption of these sera with SO abolished completely the anti-M4 antibodies but had no effect on the anti-M2 activity. The specificity of this reaction was also documented by examining 30 anti-M2/anti-M4-positive sera showing that 28 of them were positive with SO. Among ten anti-M2/anti-M8-positive but anti-M4-negative PBC sera, four became positive when tested against SO, indicating a higher sensitivity of SO for the demonstration of anti-M4. Retesting sera from 76 PBC patients with defined anti-mitochondrial antibody (AMA) profiles who had been followed for up to 18 years against SO by ELISA and complement fixation test (CFT), none of 32 patients with profile A B (positive for anti-M2 and/or anti-M9 by ELISA; benign course) but 33 of 44 patients with profile C/D (anti-M2/anti-M4 and or anti-M8 positive by CFT and or ELISA; progressive course) were positive. These data indicate that sulphite oxidase can be used in the ELISA for the detection of anti-M4 antibodies which may be of prognostic relevance.

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berg P. A., Klein R. Heterogeneity of antimitochondrial antibodies. Semin Liver Dis. 1989 May;9(2):103–116. doi: 10.1055/s-2008-1040501. [DOI] [PubMed] [Google Scholar]
  2. Berg P. A., Wiedmann K. H., Sayers T., Klöppel G., Lindner H. Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies. Lancet. 1980 Dec 20;2(8208-8209):1329–1332. doi: 10.1016/s0140-6736(80)92397-1. [DOI] [PubMed] [Google Scholar]
  3. Gershwin M. E., Coppel R. L., Mackay I. R. Primary biliary cirrhosis and mitochondrial autoantigens--insights from molecular biology. Hepatology. 1988 Jan-Feb;8(1):147–151. doi: 10.1002/hep.1840080128. [DOI] [PubMed] [Google Scholar]
  4. Guiard B., Lederer F. Amino acid sequence of the 'b5-like' heme-binding domain from chicken sulfite oxidase. Eur J Biochem. 1979 Oct 15;100(2):441–453. doi: 10.1111/j.1432-1033.1979.tb04187.x. [DOI] [PubMed] [Google Scholar]
  5. Johnson J. L., Rajagopalan K. V. The oxidation of sulphite in animals systems. Ciba Found Symp. 1979;(72):119–133. doi: 10.1002/9780470720554.ch8. [DOI] [PubMed] [Google Scholar]
  6. Johnson J. L., Rajagopalan K. V. Tryptic cleavage of rat liver sulfite oxidase. Isolation and characterization of molybdenum and heme domains. J Biol Chem. 1977 Mar 25;252(6):2017–2025. [PubMed] [Google Scholar]
  7. Kessler D. L., Rajagopalan K. V. Purification and properties of sulfite oxidase from chicken liver. Presence of molybdenum in sulfite oxidase from diverse sources. J Biol Chem. 1972 Oct 25;247(20):6566–6573. [PubMed] [Google Scholar]
  8. Klein R., Berg P. A. Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognize an epitope of glycogen phosphorylase. Clin Exp Immunol. 1990 Jul;81(1):65–71. doi: 10.1111/j.1365-2249.1990.tb05292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Klein R., Berg P. A. Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis. Clin Exp Immunol. 1988 Oct;74(1):68–74. [PMC free article] [PubMed] [Google Scholar]
  10. Klein R., Berg P. A. Demonstration of "naturally occurring mitochondrial antibodies" in family members of patients with primary biliary cirrhosis. Hepatology. 1990 Aug;12(2):335–341. doi: 10.1002/hep.1840120222. [DOI] [PubMed] [Google Scholar]
  11. Klein R., Klöppel G., Garbe W., Fintelmann V., Berg P. A. Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease. A retrospective analysis of 76 patients over 6-18 years. J Hepatol. 1991 Jan;12(1):21–27. doi: 10.1016/0168-8278(91)90903-o. [DOI] [PubMed] [Google Scholar]
  12. Meek F., Khoury E. L., Doniach D., Baum H. Mitochondrial antibodies in chronic liver diseases and connective tissue disorders: further characterization of the autoantigens. Clin Exp Immunol. 1980 Jul;41(1):43–54. [PMC free article] [PubMed] [Google Scholar]
  13. Ono H., Ito A. Transport of the precursor for sulfite oxidase into intermembrane space of liver mitochondria: binding of the precursor to outer mitochondrial membrane. J Biochem. 1984 Feb;95(2):353–358. doi: 10.1093/oxfordjournals.jbchem.a134615. [DOI] [PubMed] [Google Scholar]
  14. Rizzetto M., Swana G., Doniach D. Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 1973 Nov;15(3):331–344. [PMC free article] [PubMed] [Google Scholar]
  15. Toghrol F., Southerland W. M. Purification of Thiobacillus novellus sulfite oxidase. Evidence for the presence of heme and molybdenum. J Biol Chem. 1983 Jun 10;258(11):6762–6766. [PubMed] [Google Scholar]
  16. Weber P., Brenner J., Stechemesser E., Klein R., Weckenmann U., Klöppel G., Kirchhof M., Fintelmann V., Berg P. A. Characterization and clinical relevance of a new complement-fixing antibody--anti-M8--in patients with primary biliary cirrhosis. Hepatology. 1986 Jul-Aug;6(4):553–559. doi: 10.1002/hep.1840060402. [DOI] [PubMed] [Google Scholar]
  17. Yeaman S. J., Fussey S. P., Danner D. J., James O. F., Mutimer D. J., Bassendine M. F. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet. 1988 May 14;1(8594):1067–1070. doi: 10.1016/s0140-6736(88)91894-6. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES